F901318 - A Phase I, Double-Blind, Placebo Controlled, Multiple Ascending Oral Dose Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects

Trial Profile

F901318 - A Phase I, Double-Blind, Placebo Controlled, Multiple Ascending Oral Dose Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 May 2017

At a glance

  • Drugs F 901318 (Primary)
  • Indications Aspergillosis
  • Focus Adverse reactions
  • Acronyms ORALMAD
  • Sponsors F2G
  • Most Recent Events

    • 22 May 2017 Status changed from recruiting to completed.
    • 13 Feb 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
    • 13 Feb 2017 Planned primary completion date changed from 1 Sep 2016 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top